My Google news alert coughed up a doozy this morning. The headline read :
“Parkinson’s Disease Therapeutics Market Research Report Now Available at Research Corridor” The Republic of East Vancouver.October 7, 2016
The body of the article goes on to say that a group called Research Corridor has published a new study titled “Parkinsons Disease Therapeutics Market – Growth, Share, Opportunities, Competitive Analysis and Forecast, 2015 – 2022″. There’s not much content in the balance of the post but the reader is invited to “browse the report” via a link which I am graciously including at absolutely no cost to you here! Upon following this link,you may be so grateful that you will want to pay me for the tip but please consider it a Canadian-Thanksgiving-gift from me to you!
Should you not have the opportunity to visit the aforementioned site, let me give you the essence. For a mere 4,000 USD, you can get a subscription of sorts that will allow you to actually get the report wherein, presumably, you will be able to access data that has been compiled from, likely though not necessarily only, public data sources and neatly re-packaged under the a PD label, to support sales and marketing to the PD community.
Whoa. Wait a minute. That’s news?! Parkinson’s is an awful disease. There’s a growing PD population. It’s worldwide. How can we make some money off of this? And how can we as Research Corridor make money off of those who want to make money off of people with PD? I, for one, am not buying (even if I could afford it 🙂 ).
Sell, sell, sell.
Happy Thanksgiving for all those celebrating this weekend!